chr14-88824708-A-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001288782.1(TTC8):c.-562A>T variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.0000878 in 1,606,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001288782.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000129 AC: 3AN: 232340Hom.: 0 AF XY: 0.00000787 AC XY: 1AN XY: 127072
GnomAD4 exome AF: 0.0000942 AC: 137AN: 1454000Hom.: 0 Cov.: 31 AF XY: 0.0000789 AC XY: 57AN XY: 722598
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74294
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 8;C3150715:Retinitis pigmentosa 51 Uncertain:1
- -
Bardet-Biedl syndrome Uncertain:1
This sequence change affects the initiator methionine of the TTC8 mRNA. The next in-frame methionine is located at codon 5. This variant is present in population databases (rs747906724, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with TTC8-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at